कृपया अन्य खोज का प्रयास करें
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson’s disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York. On April 1, 2024, Acorda Therapeutics, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Ron Cohen | 67 | 1995 | Founder, CEO, President & Director |
Sandra Panem | 76 | 1998 | Independent Director |
John P. Kelley | 69 | 2008 | Independent Non-Executive Chairman |
Thomas M. Burns | 49 | 2023 | Independent Director |
Michael S. Beattie | - | - | Member of Scientific Advisory Board |
Stephen G. Waxman | - | - | Member of Scientific Advisory Board |
Mary B. Bunge | - | - | Member of Scientific Advisory Board |
James W. Fawcett | - | - | Member of Scientific Advisory Board |
Eugene M. Johnson | - | - | Member of Scientific Advisory Board |
Carl W. Cotman | 84 | - | Member of Scientific Advisory Board |
Jerry Silver | - | - | Member of Scientific Advisory Board |
Jacqueline C. Bresnahan | - | - | Member of Scientific Advisory Board |
Patrick A. Tresco | - | - | Member of Scientific Advisory Board |
Mark Tuszynski | - | - | Member of Scientific Advisory Board |
Melitta Schachner | - | - | Member of Scientific Advisory Board |
Peder K. Jensen | 69 | 2011 | Independent Director |
John W. Varian | 64 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है